Speech therapy devices maker Glottal Enterprises' CEO says that using the 2.3% medical device tax to justify layoffs is "nonsense" and little more than a political strategy to attack the Affordable Care Act.

The medical device tax isn't going to result in lost jobs if industry stakeholders play it right, according to speech therapy device maker Glottal Enterprises' CEO.
In a letter written to the editor of the Syracuse Post-Standard, Martin Rothenberg did the math and concluded that the tax would result in marginal increases in product prices and "zero effect on sales" if the company could successfully market an effective product.
"It would surely not lead us to lay off employees or shift to overseas production," he wrote.
Covidien champions positive results for the Barrett's esophagus ablation device it acquired along...
Illinois healthcare giant Abbott lands European regulatory approval for the Xience Xpedition 48,...
ALung Technologies says it's going for a Chinese regulatory nod for its Hemolung respiratory assist...
An attorney for a plaintiff suing robot-assisted surgical systems maker Intuitive Surgical says the...
The American Stroke Assn. and partners release the Spot a Stroke F.A.S.T. smartphone app to help...